Profil
David Noskowitz worked as an Executive Director, Vice President, Head, Director, Associate Director, and Manager in Regulatory Affairs at Mersana Therapeutics, Inc., Aldeyra Therapeutics, Inc., Synta Pharmaceuticals Corp., Wyeth-Ayerst Research, Bristol Myers Squibb Co., Genetics Institute LLC, and Genzyme Corp.
respectively.
He completed his undergraduate degree at the University of Rochester and his graduate degree at the University of Virginia.
Ehemalige bekannte Positionen von David Noskowitz
| Unternehmen | Position | Ende |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | General Counsel | 01.03.2020 |
| MERSANA THERAPEUTICS, INC. | General Counsel | 01.10.2018 |
| BRISTOL-MYERS SQUIBB COMPANY | General Counsel | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | General Counsel | - |
| Wyeth-Ayerst Research | General Counsel | - |
Ausbildung von David Noskowitz
| Rochester Christian University | Undergraduate Degree |
| University of Virginia | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| MERSANA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Wyeth-Ayerst Research | |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
